Chris Vernall
EVP Business Development
HCMed
Chris is currently Executive Vice President of Business Development for HCmed, based in the UK. His responsibilities include helping customers in Europe, North America and the rest of the world to progress their inhaled medicines using HCmed’s proprietary mesh nebuliser device technologies.
Chris is a Chemist by training and holds a master’s degree in Medicinal and Pharmaceutical Chemistry from Loughborough University. He also holds a master’s degree in Executive Leadership from Imperial College Business School.
Chris has worked in technical, commercial and senior leadership roles across a variety of respiratory focused CRO’s and drug delivery companies, including Nanopharm, Intertek, Aptar Pharma and Vectura (now Philips-Medisize).
He is incredibly passionate about inhaled drug product development and regularly advises companies on technical and commercial strategy for their programs. Recently, he helped to set up and chair the Inhaled and Nasal Biologics and DNA Forum, an annual conference located in Cambridge, UK, now in its fourth year. He was also previously the Chair of the Inhaled and Nasal Biologics Steering Committee in the IPAC-RS (International Pharmaceutical Aerosol Consortium – Regulatory and Science) group.